Literature DB >> 21145547

Measuring spine fracture outcomes: common scales and checklists.

Andrew J Schoenfeld1, Christopher M Bono.   

Abstract

INTRODUCTION: Although outcome instruments have been used extensively in spine surgical research, few studies at present specifically address their use in investigations regarding spine trauma. In this review we provide a summary of the outcome instruments used most frequently in spine trauma research, identify the unique challenges of studying outcomes of spine trauma patients, and propose an integrated approach that may be beneficial for future studies.
METHODS: We reviewed the use of outcome instruments applicable to spine trauma research, including generic health measures, inventories of back-specific function, pain scales, health related quality of life (HRQOL) instruments, and radiographic determinants of outcome.
RESULTS: Several inventories have been utilised to measure clinical outcomes following spinal trauma. Excluding measures of neurological function (e.g. ASIA motor score), none have been specifically validated for use with spine fractures. The SF-36, RMDQ, and ODI are amongst the most commonly used instruments. Importantly, the use of validated functional outcome measures in spine trauma research is hampered by the fact that the pre-morbid state of patients who sustain spine trauma may not be accurately represented by normative values established for the general population. The VAS is used most frequently to assess degree of neck and back pain. Most studies have relied on non-validated measures to determine radiographic results of treatment, although more elegant radiographic metrics exist.
CONCLUSIONS: Functional outcome measurement of traumatically injured spine patients is challenging because available generic and spine-specific instruments were not designed for or validated in this population. Furthermore, no single inventory is capable of capturing global data necessary to evaluate results following these injuries. Investigations seeking to quantify outcomes following spine trauma should consider the use of a combination of existing surveys in a complementary fashion that should include a generic health survey, a measure of back-specific function, and determinants of bodily pain and work-related disability.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21145547     DOI: 10.1016/j.injury.2010.11.040

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Health-care costs of conservative management of spine fractures in trauma patients.

Authors:  Efe Levent Aras; Cody Bunger; Ebbe Stender Hansen; Rikke Søgaard
Journal:  Eur Spine J       Date:  2016-10-21       Impact factor: 3.134

Review 2.  Outcome Instruments in Spinal Trauma Surgery: A Bibliometric Analysis.

Authors:  Holt S Cutler; Javier Z Guzman; James Connolly; Motasem Al Maaieh; Branko Skovrlj; Samuel K Cho
Journal:  Global Spine J       Date:  2016-03-07

3.  "How to measure the outcome in the surgical treatment of vertebral compression fractures? A systematic literature review of highly cited level-I studies".

Authors:  Sonja Häckel; Angela A Renggli; Christoph E Albers; Lorin M Benneker; Moritz C Deml; Sebastian F Bigdon; Sufian S Ahmad; Sven Hoppe
Journal:  BMC Musculoskelet Disord       Date:  2021-06-24       Impact factor: 2.362

4.  Life impact of ankle fractures: qualitative analysis of patient and clinician experiences.

Authors:  Steven M McPhail; Joel Dunstan; Julie Canning; Terry P Haines
Journal:  BMC Musculoskelet Disord       Date:  2012-11-21       Impact factor: 2.362

5.  Reliability and Validity of the English Version of the AOSpine PROST (Patient Reported Outcome Spine Trauma).

Authors:  Said Sadiqi; Marcel F Dvorak; Alexander R Vaccaro; Gregory D Schroeder; Marcel W Post; Lorin M Benneker; Frank Kandziora; S Rajasekaran; Klaus J Schnake; Emiliano N Vialle; F Cumhur Oner
Journal:  Spine (Phila Pa 1976)       Date:  2020-09-01       Impact factor: 3.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.